In the study by Pfirschke et al., immunogenic chemotherapy, such as oxaliplatin and cyclophosphamide, induced tumor cell release of HMGB1, and activation of TLR4 on DCs that, in turn, stimulate antitumor CD8 + T cells. Here, TLR4 is linked to neoplasm.